Navigation Links
Dr. Lance H. Brown President-Elect of Dermatologic Society of Greater New York Fights Misconceptions About Sun Protection and Skin Care in Support of Skin Cancer Awareness Month - May
Date:5/8/2008

linically proven cosmetic procedures including laser treatments, peels, topical solutions, fillers and injections.

Dr. Brown is Board Certified by the American Board of Dermatology, teaches as an Assistant Clinical Professor of Dermatology at New York University School of Medicine and serves as President-Elect of the Dermatologic Society of Greater New York.

A sought-out authority in his field, Dr. Brown has addressed dozens of dermatological conferences, and frequently publishes in prominent journals including the Journal of the American Academy of Dermatology, Skin and Aging and Cosmetic Dermatology.
For more information: http://www.drlancebrown.com

Press Contact:

Paula Rosado 917.446.5281

paula@paularosadopr.com


'/>"/>
SOURCE Dr. Lance H. Brown
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2

Related medicine news :

1. Longer ambulance journeys boost death risk for seriously ill patients
2. Two studies published in the Lancet
3. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
4. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
5. A chocolate cookie a day puts 20 pounds on an energetically-balanced kid in 4 years
6. Study expected to boost research for hearing and balance therapies
7. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
8. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
9. Paramedics can provide an effective alternative to standard ambulance service in the community
10. Sallie Mae Employees Receive Award for Largest National Team at Lance Armstrong Foundation Fundraising Events
11. Decision-makers seek internal balance, not balanced alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Storrs HealthDay Reporter , , TUESDAY, May 22 ... sleep apnea, a common cause of snoring and daytime ... hazard associated with the condition -- the risk of ... the number of new cases of high blood pressure ... positive airway pressure therapy, or CPAP, for either about ...
(Date:5/22/2012)... team of global partners has tasked itself with ... children of developing nations. , "Mobility to a ... between education versus no education, societal engagement versus ... said David Dausey, Ph.D., director of the Mercyhurst ... partnership. , Dausey recently traveled to Guanajuato, ...
(Date:5/22/2012)... By Maureen Salamon HealthDay Reporter , , ... U.S. advisory panel no longer recommends that men ... blood test, men should ask their doctors for ... experts say. Urologists and cancer experts dismissed ... Force,s criticism of the PSA test will set ...
(Date:5/22/2012)... Scientists at Virginia Commonwealth University Massey Cancer ... a new therapy for acute myeloid leukemia (AML) ... sorafenib kill leukemia cells much more effectively when ... Recently published in the journal Blood, the results ... Shirley Carter Olsson and Sture Gordon Olsson Chair ...
(Date:5/22/2012)... about teenage pregnancy -- "16 and Pregnant" and "Teen ... the shows glamorized teenage pregnancy, while supporters said they ... University professor suggests they,re both right. , The study, ... Culture, focused on female students because of the ... , When the programs were under development, MTV sought ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:New initiative aims to increase mobility for disabled children worldwide 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 2Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 3
... will develop breast cancer in her life. But how much ... ,Breast cancer specialists from the University of Michigan Comprehensive Cancer ... necessary. And in some cases the fear paralyzes women and ... successful treatment. ,Here, experts debunk some of the ...
... dental care in United Kingdom, and a munificent grant of ... don’t figure anywhere on the NHS dental list. , ... the NHS registrations, down by a 42000 enrollments. This, notwithstanding ... dentists to ensure registrations are maintained. Yet, it has not ...
... death due to Japanese encephalitis, the death toll since ... ,According to the Additional Director (Health) Umakant ... been reported from several parts of the district since ... people were undergoing treatment at the BRD Medical College ...
... British Journal of Sports Medicine says that a woman's ... her fingers//. Researchers said that the finding could provide ... vulnerability to serious disease, intellectual ability, certain personality traits, ... in this area has so far focused exclusively on ...
... are investigating common painkiller drugs after researchers warned ... of heart attack//. ,The new data, ... the drugs doubled heart attack risk. ... such as diclofenac, etodolac, ibuprofen, indomethacin, ketoprofen, ketorolac, ...
... sites could face the risk of developing lung cancer although ... ,Researchers studied over 200 women under the age of ... healthy women in Teeside, northeast England, reported Newswise wire. ... this particular area of England, where heavy industries expanded rapidly ...
Other Medicine News:Health News:16 Common Myths About Breast Cancer 2Health News:16 Common Myths About Breast Cancer 3Health News:16 Common Myths About Breast Cancer 4Health News:16 Common Myths About Breast Cancer 5
(Date:5/22/2012)... MAY 22, 2012 ThermoGenesis Corp. (NASDAQ: ... for the processing, storage and administration of cell therapies, ... for its AXP® AutoXpress® Platform (AXP) used for the ... to initiate commercial activities in the country later this ... in the region,s cord blood market through our efforts ...
(Date:5/22/2012)... NEWTON, Mass., May 22, 2012  Halo ... novel therapeutics for rare fibrotic diseases, announced ... totaling $1.1 million from 12 not-for-profit foundations serving ... use the funds to expedite the phase ... candidate for Duchenne muscular dystrophy (DMD). HT-100, ...
(Date:5/22/2012)...  Systech International, a leading provider of Packaging ... integrity and authenticity, today announced that David F. ... Mr. Harty will be responsible for ... Cloud Products and Solutions, and aligning the company,s ... Harty has a unique perspective of the value ...
Breaking Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 3David F. Harty Joins Systech International as Vice President 2New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting Related Falls in Healthcare Facilities 24747 1New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting Related Falls in Healthcare Facilities 24747 2The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 24744 1The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 24744 2Prenatal exposure to combustion related pollutants and anxiety attention problems in young children 89857 1Prenatal exposure to combustion related pollutants and anxiety attention problems in young children 89857 2
... presents Phase 1 results demonstrating clinical activity ... previously treated with bortezomib, and provides an update on ... of perifosine in combination with dexamethasone, NEW YORK, ... today announced that positive phase 1 & phase 2 ...
... Data from Pivotal Study Show Bendamustine Produced a Significant ... in Overall Response Rate and Progression Free Survival, ... today that in a pivotal study of treatment-naive patients,with ... had better clinical outcomes compared to patients,treated with chlorambucil, ...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 7TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 2TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 3TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 4TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 5
For the quantitative determination of creatinine in serum. Fixed Time Reaction measured at 540 nm. Linearity: 25 mg/dl. Express Kit with Ready-to-Use Liquid....
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Medicine Products: